Compound Detail
CHEMBL2180604
TAK-593 Phase I
Enter ChEMBL ID:
Free Research Context
This compound will appear in recent viewed items on the research home for this browser.
Research home
View demo workspace
Phase I
Basic Information
| ChEMBL ID | CHEMBL2180604 |
| Name | TAK-593 |
| Phase | Phase I |
| Structure Type | MOL |
| InChI Key | DZFZXPPHBWCXPQ-UHFFFAOYSA-N |
18
Targets
25
Activities
2
Assay Types
14
PK Parameters
20
Publications
2
Known Names
1
Indications
2
Mechanisms
Molecular Properties
445.5
MW (Da)
3.47
ALogP
8
HBA
2
HBD
115.4
PSA (Ų)
0.47
QED
0
Ro5 Violations
6
Rot. Bonds
Drug Information
| Molecule Type | Small molecule |
| Chirality | Achiral |
Mechanism of Action
| Mechanism | Action Type | Target | Direct | Efficacy |
|---|---|---|---|---|
| Platelet-derived growth factor receptor inhibitor | INHIBITOR | Platelet-derived growth factor receptor | ✓ | ✓ |
| Vascular endothelial growth factor receptor inhibitor | INHIBITOR | Vascular endothelial growth factor receptor | ✓ | ✓ |
Indications
Neoplasms
Activity Summary
IC50 13 meas. best 10.03
Kd 12 meas. best 8.0
Target Activity Profile
Pharmacokinetic Data
| Parameter | Value | Units | Species |
|---|---|---|---|
| AUC | 1511.0 | ng.hr.mL-1 | Macaca fascicularis |
| AUC | 226.0 | ng.hr.mL-1 | Rattus norvegicus |
| AUC | 1313.0 | ng.hr.mL-1 | Macaca fascicularis |
| AUC | 571.0 | ng.hr.mL-1 | Rattus norvegicus |
| CL | 3.183 | mL.min-1.kg-1 | Macaca fascicularis |
| CL | 7.3 | mL.min-1.kg-1 | Rattus norvegicus |
| Cmax | 289.58 | nM | Macaca fascicularis |
| Cmax | 125.71 | nM | Rattus norvegicus |
| F | 57.6 | % | Macaca fascicularis |
| F | 19.8 | % | Rattus norvegicus |
| MRT | 11.0 | hr | Macaca fascicularis |
| MRT | 3.3 | hr | Rattus norvegicus |
| Tmax | 2.8 | hr | Macaca fascicularis |
| Tmax | 1.3 | hr | Rattus norvegicus |
Activity Data Samples
Top measurements by pChEMBL value
Literature References
| PubMed | DOI | Target Context | # Activities |
|---|---|---|---|
| 23498918 | 10.1016/j.bmc.2013.01.074 | Rattus norvegicus | 8 |
| 23498918 | 10.1016/j.bmc.2013.01.074 | Cynomolgus monkey | 8 |
| 29191878 | 10.1126/science.aan4368 | Unchecked | 4 |
| 23498918 | 10.1016/j.bmc.2013.01.074 | Mus musculus | 4 |
| 23498918 | 10.1016/j.bmc.2013.01.074 | A549 | 3 |
| 23498918 | 10.1016/j.bmc.2013.01.074 | Vascular endothelial growth factor receptor 2 | 3 |
| - | 10.6019/CHEMBL4495565 | SARS-CoV-2 | 2 |
| 23498918 | 10.1016/j.bmc.2013.01.074 | Lung | 2 |
| 23498918 | 10.1016/j.bmc.2013.01.074 | Plasma | 2 |
| 23498918 | 10.1016/j.bmc.2013.01.074 | No relevant target | 2 |
| - | 10.6019/CHEMBL4808148 | Histone deacetylase 6 | 2 |
| 23498918 | 10.1016/j.bmc.2013.01.074 | Platelet-derived growth factor receptor alpha | 1 |
| 23498918 | 10.1016/j.bmc.2013.01.074 | Liver microsomes | 1 |
| 23498918 | 10.1016/j.bmc.2013.01.074 | Liver | 1 |
| 23498918 | 10.1016/j.bmc.2013.01.074 | Vascular endothelial growth factor receptor 3 | 1 |
| 23098265 | 10.1021/jm301085w | Vascular endothelial growth factor receptor 3 | 1 |
| 23498918 | 10.1016/j.bmc.2013.01.074 | Platelet-derived growth factor receptor beta | 1 |
| 23498918 | 10.1016/j.bmc.2013.01.074 | Macrophage colony-stimulating factor 1 receptor | 1 |
| 23498918 | 10.1016/j.bmc.2013.01.074 | Proto-oncogene tyrosine-protein kinase receptor Ret | 1 |
| 34607244 | 10.1016/j.ejmech.2021.113867 | Platelet-derived growth factor receptor beta | 1 |
Data from ChEMBL 36 via Core Engine